{'fraction_non_alphanumeric': 0.01070154577883472, 'fraction_numerical': 0.0047562425683709865, 'mean_word_length': 5.145985401459854, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Asthma, sulfur dioxide and the clean air act.

Laboratory findings on the effects of sulfur dioxide in patients with asthma are related to theories about the mechanisms of bronchial hyperreactivity, an abnormality that may be fundamental to the pathogenesis of asthma and then to questions of national policy on air quality. Work has shown that people with asthma are abnormally sensitive to inhalation of sulfur dioxide and that bronchospasm may develop if they pursue activities that require light exercise while breathing air containing a level of sulfur dioxide permitted by current ambient air-quality standards. The provisions of the Clean Air Act of 1970 require that sensitive groups in the population be protected against adverse health effects, and our data therefore indicate the need for a short-term standard for sulfur dioxide.